TY  - GEN
AU  - Eggermont,A M M
AU  - Chiarion-Sileni,V
AU  - Grob,J-J
TI  - Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
SN  - 1474-5488
PY  - 2015///0813
N1  - Publication Type: Published Erratum
UR  - https://doi.org/10.1016/S1470-2045(15)70271-8
ER  -